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Abstract 
Partial or complete chromosome gains are frequently 
found in hematological malignancies, but the 
unbalanced der(3)t(3;3) is a relatively rare 
chromosome anomaly. 
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Disease 
Myeloid malignancies and lymphomas. 
Phenotype/cell stem origin 
Myeloid malignancies in 3 cases: 1 refractory 
anemia with excess blasts-1 (RAEB) (Yamamoto et 
al., 2004), 1 acute erythroleukemia (Olopade et al,  
1992) and the present patient diagnosed with acute 
myeloid leukemia (AML). In addition, there was a 
66- years old female patient with 3q23 breakpoint 
diagnosed with idiopathic myelofibrosis (Reilly et 
al., 1997). 4 patients had various forms of 
lymphomas: 1 angioimmunoblastic T-cell 
lymphoma (Levine et al., 1985), 1 follicular 
lymphoma (Schlegelberger et al., 1990) 1 diffuse 
large B-cell lymphoma (Goyns et al., 1993) and 1 
mantle cell lymphoma (Wlodarska et al., 19991).
Figure 1. Karyotype of the patient showing the unbalanced translocation of chromosome 3 and associated with 13q deletion. 
Partial karyotypes showing the rearranged chromosome 3 (A). Fluorescence in situ hybridization with Keratech MECOM t(3;3); 
inv(3)(3q26) also known as EVI t(3;3); inv(3)(3q26) break-apart probe (Kreatech Biotechnology B.V., NL) showing 3 copies of the 
gene located on 3q26 as a result of the unbalanced translocation (B). 
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Epidemiology 
Only 6 reported patients (3M/3F) aged 56, 66, 60 and 
75 years (2 unknown) and the present 46-years old 
female patient (unpublished data). 
Clinics 
The present patient was diagnosed with AML, NOS 
in 2006 and achieved complete hematological 
remission after chemotherapy but relapsed 4 years 
later. After bone marrow transplantation she 
maintained her remission status until November 
2017 when she relapsed with 26% blasts in the 
blood. 
Prognosis 
Found as part of highly complex karyotypes, 




Presents as 1 normal chromosome 3 and a 
der(3)t(3;3) chromosome in 6 and as 2 normal 
chromosomes 3 and +der(3) in 1 patient. 
Additional anomalies 
Highly complex karyotypes in both myeloid and 
lymphoid malignancies, found in a sideline with 
del(13q) as a sole additional anomaly in the 
idiopathic myelofibrosis  patient with 3q23 
breakpoint (Reilly et al., 1997). Found at relapse 
after bone marrow transplantation as a sole anomaly 
in 10 and in association with del(13)(q22?) in 5 out 
of the 25 examined metaphases in the present AML 
patient. 




der(3)t(3;3)(p25-26;q12-21) is a rare cytogenetic 
abnormality that has been observed in sporadic cases 
of myeloid malignancies and lymphomas. Mainly 
found as part of complex karyotypes with multiple 
numerical and structural anomalies, reflecting 
stepwise development of chromosomal 
abnormalities. The result of this unbalanced 
translocation is partial trisomy of the long arm of 
chromosome 3 causing deregulation of proto-
oncogenes via gene dosage effect that may lead to 
their overexpression. 
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